Winston-Salem, North Carolina, June 17, 2005 Onconix Inc. (formerly Cervius Inc.), announced today an investment from the Inception Micro Angel Fund (IMAF). “This investment will catalyze our efforts to expand our cancer diagnostic portfolio beyond cervical cancer to include tests for prostate, breast, ovarian, colon and other cancer types,” said Eric Button, chairman of the company. “We are implementing a very aggressive company acquisition and licensing strategy to acquire various cancer diagnostic technologies. The goal is to rapidly increase critical mass to create a formidable company force in the rapidly expanding field of cancer biomarkers.”
